CD109 (CD109) (Middle Region) Peptid
CD109
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle CD109 Produkte
- CD109
- Protein Region
- Middle Region
- Spezies
- Human
- Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- KLYWSKVKAE PSEKVSLRIS VTQPDSIVGI VAVDKSVNLM NASNDITMEN
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-CD109 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CD109
- Synonyme
- CPAMD7 Peptide, RP11-525G3.1 Peptide, CD109 Peptide, 9930012E15Rik Peptide, AI480638 Peptide, GARP Peptide, CD109 molecule Peptide, CD109 antigen Peptide, CD109 Peptide, Cd109 Peptide, cd109 Peptide
- Hintergrund
-
This gene encodes a member of the alpha2-macroglobulin/complement superfamily. The encoded GPI-linked glycoprotein is found on the cell surface of platelets, activated T-cells, and endothelial cells. The protein binds to and negatively regulates signaling of transforming growth factor beta (TGF-beta). Multiple transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: CPAMD7, DKFZp762L1111, FLJ38569, FLJ41966, RP11-525G3.1
Protein Size: 1368 - Molekulargewicht
- 151 kDa
- Gen-ID
- 135228
- NCBI Accession
- NM_001159588, NP_001153060
-
Sie sind hier:
